|
COVID-19: Sun Pharmaceuticals business update
|
Mark Hagler, senior vice president, head of Ophthalmics, Oncology and LTC at Sun Pharmaceuticals, shares a business update on how the company has responded and continued operations during the coronavirus pandemic.
|
Watch here
|